http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9218485-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36e8050eec40967e1cbc39ff89f2607d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-54 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-54 |
| filingDate | 1992-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b49ed9b6b0d8386e337fc400c15094c |
| publicationDate | 1992-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9218485-A1 |
| titleOfInvention | Anti-cancer coumpounds |
| abstract | Compounds of formula (I), in which R1? is A-N(O)R'R' and R2?, R3? and R4? are each separately selected from hydrogen, X and NH-A-N(O)R'R' wherein X is hydroxy, halogeno, amino, C1-4? alkoxy or C2-8? alkanoyloxy, A is a C2-4? alkylene group with a chain length between N or NH and N(O)R'R' of at least 2 carbon atoms and R' and R' are each separately selected from C1-4? alkyl groups and C2-4? hydroxyalkyl and C3-4? dihydroxyalkyl groups in which the carbon atom attached to the nitrogen atom does not carry a hydroxy group and no carbon atom is substituted by two hydroxy groups, or R' and R' together are a C2-6? alkylene group which with the nitrogen atom to which R' and R' are attached forms a heterocyclic group having 3 to 7 atoms in the ring, and physiologically acceptable salts thereof are of value in the treatment of cancer. |
| priorityDate | 1991-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.